Gabrielle Silver is a specialist in life sciences and co-leads the global healthcare practice at Brunswick. She advises across the segment with a focus on corporate positioning, crisis management and campaigns.
She previously led the GE Global Strategic Marketing Organisation with a focus on Neuroscience and Primary Care offerings. She spent nine years in global roles within the pharmaceutical sector, including Eisai and Bristol Myers Squibb, where she was responsible for the development, launch and commercialization of innovative therapies in the fields of neuroscience, psychiatry and pain management.
Having qualified as a doctor in London and practiced as an anaesthetist, Gabrielle is fully familiar with the UK public sector and now serves as a non-executive for an NHS Trust. She also serves as Director to a small US biopharmaceutical company, Opiant Inc. which focuses on the development of drugs for addictive disorders.